These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35855155)

  • 1. Extensive spontaneous cervical epidural hematoma due to oral anticoagulant (dabigatran) successfully treated with reversal agent idarucizumab alone.
    Uddin SA; Roma K; Ross L; Hanna G; Drazin D; Kim TT
    Surg Neurol Int; 2022; 13():259. PubMed ID: 35855155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe Burr Hole Surgery for Chronic Subdural Hematoma Using Dabigatran with Idarucizumab.
    Arai N; Mine Y; Kagami H; Maruyama M; Daikoh A; Inaba M
    World Neurosurg; 2018 Jan; 109():432-435. PubMed ID: 29054780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous Cervical Spinal Epidural Hematoma Associated with Dabigatran.
    Mathais Q; Esnault P; Cruc M; Bernard C; Prunet B; Gaillard PE
    World Neurosurg; 2018 Apr; 112():264-266. PubMed ID: 29425981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.
    Reilly PA; van Ryn J; Grottke O; Glund S; Stangier J
    Am J Med; 2016 Nov; 129(11S):S64-S72. PubMed ID: 27569674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idarucizumab, a specific reversal agent for dabigatran: mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects.
    Reilly PA; van Ryn J; Grottke O; Glund S; Stangier J
    Am J Emerg Med; 2016 Nov; 34(11S):26-32. PubMed ID: 27707528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidural hematoma and intraoperative hemorrhage in a spine trauma patient on Pradaxa (dabigatran).
    Truumees E; Gaudu T; Dieterichs C; Geck M; Stokes J
    Spine (Phila Pa 1976); 2012 Jun; 37(14):E863-5. PubMed ID: 22343277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idarucizumab: A Review as a Reversal Agent for Dabigatran.
    Syed YY
    Am J Cardiovasc Drugs; 2016 Aug; 16(4):297-304. PubMed ID: 27388764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
    Ohtani T; Sintoku R; Yajima T; Kaneko N
    J Med Case Rep; 2019 Dec; 13(1):390. PubMed ID: 31875786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Dabigatran Fast Reversals in a 4-month Period - a Case Report.
    Fagundes V; Mesquita M
    Eur J Case Rep Intern Med; 2019; 6(12):001311. PubMed ID: 31893202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
    Marino KK; Santiago RA; Dew RB; Berliner N; Connors JM; Connell NT; Tucker JK
    Pharmacotherapy; 2016 Oct; 36(10):e160-e165. PubMed ID: 27581709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idarucizumab for a traumatic head injury patient taking dabigatran.
    Maruyama S; Hayakawa K; Kanayama S; Iwamura H; Wada D; Saito F; Nakamori Y; Kuwagata Y
    Int J Emerg Med; 2018 Oct; 11(1):41. PubMed ID: 31179930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients.
    Hieber M; Hollasch H; Heck D; Mächtel M; Geisen U; Niesen WD; Brich J; Harloff A
    J Thromb Thrombolysis; 2018 Jul; 46(1):12-15. PubMed ID: 29633066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: a case report of first use in Latin America.
    Izaguirre Ávila R; Bahena López JE; Cortina de la Rosa E; Hernández Márquez MÁ
    Eur Heart J Case Rep; 2019 Jun; 3(2):. PubMed ID: 31449648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The first use of iv. idarucizumab for dabigatran reversal in Hungary].
    Driesz L; Barabás É; Bodócs I; Szántó Z; Herr G; Bencsik G; Pál L; Borbola J
    Orv Hetil; 2017 Mar; 158(10):387-392. PubMed ID: 28270004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
    Meyer D; Chu F; Derry K; Hailey L
    J Clin Neurosci; 2019 Jan; 59():355-357. PubMed ID: 30309801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of Dabigatran Bleeding and Coagulopathy Using Idarucizumab in a Patient With Acute Kidney Injury.
    Vidal J; DePalma R; Forouzan L
    P T; 2018 Dec; 43(12):748-749. PubMed ID: 30559587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematoma.
    Edwards G; Roman C; Jithoo R; Mitra B
    Trauma Case Rep; 2018 Feb; 13():46-49. PubMed ID: 29644298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review.
    Thibault N; Morrill AM; Willett KC
    Am J Ther; 2018; 25(3):e333-e338. PubMed ID: 27175894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Dabigatran with Idarucizumab.
    Sodha NR; Sellke FW
    Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):889-93. PubMed ID: 27362456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence Supporting Idarucizumab for the Reversal of Dabigatran.
    Pollack CV
    Am J Med; 2016 Nov; 129(11S):S73-S79. PubMed ID: 27568285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.